Published recall report · See noticeUpdated · 5 yr 5 mo ago
Apotex Corp. recall: Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0
Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0
Current recall status is unverified. FDA does not update drug-enforcement status after publication. Check the latest official information or ask a pharmacist.
What to do
Check the lot number on your pack against this recall and follow the firm's instructions. Do not stop taking a prescribed medicine without talking to a pharmacist or doctor first.
FDA public enforcement report, opens in a new tabWhich products
Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0
- Producer
- Apotex Corp.
- Brand
- GUANFACINE EXTENDED-RELEASE
RX1662
- Dates on pack
- Lot #: RX1662, RX1663, RX1664 Exp. 11/2022
360505392810
- Dates on pack
- Lot #: RX1662, RX1663, RX1664 Exp. 11/2022
360505392810
More detail
Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate
In the news
Reporting from news publishers. Follow the official notice for product advice.
No news stories about this recall yet.